Smith, Kline & French Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Philadelphia PA United States (1891)
Status: Acquired by SmithKline Beckman (1982) → now GlaxoSmithKline (2000)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1957
triflupromazine (vesprin)
First NDA Approval
1957
triflupromazine (vesprin)
Last Known Activity
1971

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree